Merck's Proquad Gets FDA Nod
6th Sep 2005, 23:08 GMT
Merck received FDA approval for its drug Proquad, a single vaccine to prevent measles, mumps, rubella and chicken pox in children.
Latest news from WSJ.com: US Business:
- Merck's Arcoxia Draws Mixed Reviews
- Benetton Top Executives Resign
- Apple Names Rosenberg General Counsel
- Gutierrez Aims to Help U.S. Business in China
- Tyson Swings to Loss as Demand Wanes
- Eddie Bauer Agrees to Be Acquired
- Web Companies Seek Review of Fees
- Delta Cuts Bargain Fares
- Illumina to Buy Solexa for $600 Million
- BlackJack Is BlackBerry's Newest Rival